Nozaki, and H
It is not designed for human consumption, veterinary application, or clinical use of any kind
Preparations of 5-Aminosalicylate (5-ASA) for Treatment of Ulcerative Colitis Generic name Mesalamine Proprietary name Rowasa Canasa Pentasa Asacol Delzicol Apriso Lialda Olsalazine Sulfasalazine Balsalazide Dipentum Azulfidine Colazal Giazo Daily dose, ga Formulation Sites of delivery Active Maintenance Enema suspension Suppository Ethylcellulose-coated granules (controlled-release) Eudragit-Scoated tablets (dissolves at pH 7.0) Eudragit-Scoated tablets (dissolves at pH 7.0) Enteric coating (dissolves at pH 6) around polymer matrix Enteric coating (dissolves at pH 7) around polymer matrix with lipophilic and hydrophilic matrices 5-ASA dimer linked by azo bond 5-ASA linked to sulfapyridine by azo bond 5-ASA linked to inert carrier by azo bond 5-ASA linked to inert carrier by azo bond From rectum to splenic flexure Rectum Duodenum, jejunum, ileum, colon Terminal ileum, colon Terminal ileum, colon Terminal ileum, colon 4 1 2-4 2.4-4.8 2.4-4.8 1.5 4b 1b 1.5-4 1.6-4.8 1.6-4.8 1.5 Terminal ileum, colon 2.4-4.8 2.4 Colon Colon Colon Colon 2-3 2-4 6.75 6.6 1 2-4 4.5-6.75 4.4-6.6 a Dose ranges reflect those commonly used in clinical practice and are broader than those specifically studied in clinical trials
Treatment with folate, 5 mg daily, and vitamin B12 replacement produces rapid improvement in the anemia, glossitis, and weight loss in many patients with tropical sprue
Phillips DJ, Jones KL, McGaw DJ, Groome NP, Smolich JJ, Prsson H, et al
Systemic side effects are not well-documented in human studies at therapeutic doses
